Next Article in Journal
Enhancing Oral Delivery of Biologics: A Non-Competitive and Cross-Reactive Anti-Leptin Receptor Nanofitin Demonstrates a Gut-Crossing Capacity in an Ex Vivo Porcine Intestinal Model
Previous Article in Journal
Preparation, Optimization, and In-Vitro Evaluation of Brusatol- and Docetaxel-Loaded Nanoparticles for the Treatment of Prostate Cancer
Previous Article in Special Issue
Recent Advances in Polycaprolactones for Anticancer Drug Delivery
 
 
Review

Article Versions Notes

Pharmaceutics 2024, 16(1), 115; https://doi.org/10.3390/pharmaceutics16010115
Action Date Notes Link
article pdf uploaded. 16 January 2024 14:55 CET Version of Record https://www.mdpi.com/1999-4923/16/1/115/pdf-vor
article xml file uploaded 17 January 2024 04:45 CET Original file -
article xml uploaded. 17 January 2024 04:45 CET Update -
article pdf uploaded. 17 January 2024 04:45 CET Updated version of record https://www.mdpi.com/1999-4923/16/1/115/pdf-vor
article html file updated 17 January 2024 04:46 CET Original file -
article pdf uploaded. 17 January 2024 10:02 CET Updated version of record https://www.mdpi.com/1999-4923/16/1/115/pdf-vor
article html file updated 17 January 2024 10:03 CET Update -
article pdf uploaded. 17 January 2024 10:27 CET Updated version of record https://www.mdpi.com/1999-4923/16/1/115/pdf-vor
article html file updated 17 January 2024 10:28 CET Update -
article xml file uploaded 18 January 2024 02:52 CET Update -
article xml uploaded. 18 January 2024 02:52 CET Update https://www.mdpi.com/1999-4923/16/1/115/xml
article pdf uploaded. 18 January 2024 02:52 CET Updated version of record https://www.mdpi.com/1999-4923/16/1/115/pdf
article html file updated 18 January 2024 02:53 CET Update https://www.mdpi.com/1999-4923/16/1/115/html
Back to TopTop